ArticleBlood cancer discovery2023

Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.